Biotechnology

IPO Preview: SAVU, KWE, BFAI

The upcoming IPOs in focus this week include lab-grown organ outfit BioLife4D Corp, non-lethal weapons developer Kwesst and AI healthcare specialists BullFrog AI.

Daily Stock Watch: Is Veeva Systems a Buy?

Shares of Veeva Systems Inc (NYSE: VEEV) are markedly lower on Friday on the back of earnings disappointment. But with few competitors and a growing niche, is VEEV stock a good investment?

Daily Stock Watch: HZNP Climbs on Buyout Rumblings

Horizon Therapeutics (NASDAQ: HZNP) has seen its share price leap on the back of M&A news, but does that mean HZNP stock is a good investment?

Daily Stock Watch: ISEE Stock's Eye Watering Rise

Iveric Bio Inc (NASDAQ: ISEE) has seen its share price leap following a new FDA designation. However, with good news for a key competitor emerging too, is ISEE stock a good investment?

IPO Outlook: GNLX, BFAI

The IPOs to look out for this week include cancer treatment outfit Genelux Corporation and medicine development and AI specialist BullFrog AI.

Daily Stock Watch: Biotech Stock BLI Rises 20%

Berkeley Lights (NASDAQ: BLI) released Q3 earnings with record recurring revenues, leading the BLI share price to rise 20%.

IPO Outlook: BFAI, SNAL, ACRV

The IPOs to look out for this week include medicine development and AI specialist BullFrog AI, game developer Snail and biopharma outfit Acrivon Therapeutics.

Daily Stock Watch: Aurinia Pharmaceuticals Slashes Sales Forecast

Aurinia Pharmaceuticals (NASDAQ: AUPH) has seen its share price fall yet further as Q3 results included a cut in sales forecast. But is AUPH stock worth investing in?

Daily Stock Watch: ESSA Pharma Dips on Trial Suspension

Though ESSA Pharma Inc (NASDAQ: EPIX) saw its share price soar last week on strong pre-clinical news, a trial hiccup is giving investors jitters. But is EPIX stock a good investment?

IPO Outlook: MBLY, ASPI, INTS

The coming week's IPOs could include offerings from Mobileye Global (NASDAQ: MBLY), ASP Isotopes (NASDAQ: ASPI) and Intensity Therapeutics (NASDAQ: INTS)

Daily Stock Watch: IMUX Stock Tumbles on Placebo Performance

Immunic Inc (NASDAQ: IMUX) has lost three quarters of its share price after investors were left unimpressed with clinical trial data. But is IMUX stock a good investment?

IPO Outlook: ALPX, BMR, ASPI, INTS, PRME

The coming week's IPOs could include offerings from Alopexx (NASDAQ: ALPX), Beamr Imaging (NASDAQ: BMR), ASP Isotopes (NASDAQ: ASPI), Intensity Therapeutics (NASDAQ: INTS) and Prime Medicine (NASDAQ: PRME).

Daily Stock Watch: MIST Stock Falters Despite Trial Success

One stock heading lower at the start of this week is biopharma outfit Milestone Pharmaceuticals (NASDAQ: MIST). But is MIST stock a good investment?

IPO Outlook: ALPX, BMR, CTM

Some of the IPOs slated for the week ahead include Alopexx (NASDAQ: ALPX), Beamr Imaging (NASDAQ: BMR) and Castellum (NYSEAMERICAN: CTM).

Daily Stock Watch: PRVB Stock Buoyant Following Sanofi Deal

Having just signed a major deal with a top pharma player, Provention Bio (NASDAQ: PRVB) is attracting investors' attention. But is PRCB stock a good investment?